FY2024 EPS Forecast for Ascend Wellness Decreased by Analyst

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Atb Cap Markets cut their FY2024 EPS estimates for shares of Ascend Wellness in a report released on Tuesday, November 12th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings per share of ($0.40) for the year, down from their previous forecast of ($0.32). The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.32) per share. Atb Cap Markets also issued estimates for Ascend Wellness’ Q4 2024 earnings at ($0.08) EPS, FY2026 earnings at ($0.12) EPS, FY2027 earnings at ($0.11) EPS and FY2028 earnings at ($0.09) EPS.

Ascend Wellness Trading Down 6.8 %

Shares of AAWH opened at $0.47 on Friday. The company has a debt-to-equity ratio of 2.61, a quick ratio of 1.29 and a current ratio of 1.47. The company has a market cap of $99.66 million, a price-to-earnings ratio of -1.13 and a beta of 1.69. The stock has a fifty day moving average price of $0.82 and a two-hundred day moving average price of $0.95. Ascend Wellness has a 52-week low of $0.42 and a 52-week high of $1.82.

Ascend Wellness (OTC:AAWH) last posted its earnings results on Tuesday, November 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.03). The firm had revenue of $141.65 million during the quarter, compared to the consensus estimate of $144.13 million. Ascend Wellness had a negative net margin of 15.47% and a negative return on equity of 72.18%.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.